Success Stories & Lessons Learned: TAVNEOS (Avacopan) – an Oral Inhibitor of the Complement C5a Receptor for the Treatment of ANCAAssociated Vasculitis
Time: 4:00 pm
day: Day One
Details:
• Providing a disease and biology overview
• Sharing experiences from non-clinical and clinical development
• Addressing lessons learned from the journey
